Enzo Biochem, Inc. (NYSE:ENZ)

CAPS Rating: 2 out of 5

The Company is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and a provider of diagnostic services to the medical community.

Recs

0
Player Avatar MC40 (58.47) Submitted: 8/23/2008 9:09:10 PM : Outperform Start Price: $13.64 ENZ Score: -91.28

They're makin' money.

Featured Broker Partners


Advertisement